Detailed ExplanationNLE · Cardiovascular NursingReal content

NLE Cardiovascular Nursing — Coronary Artery Disease, Angina and Myocardial InfarctionDetailed Explanation

Summary Concepts Notes Revision Deep Dive Slides Flashcards Mistakes Cheat Mnemonics Templates

Detailed explanations for NLE Cardiovascular Nursing — Coronary Artery Disease, Angina and Myocardial Infarction. This page treats you like a serious reviewer: we unpack the concepts thoroughly, show worked examples of how Professional Regulation Commission (PRC) — Board of Nursing frames Coronary Artery Disease, Angina and Myocardial Infarction questions, and explain the underlying reasoning that gets you to the right answer every time.

Exam context

The Philippine Nurse Licensure Examination (PNLE) is conducted by Professional Regulation Commission (PRC) — Board of Nursing and is scheduled for Bi-annual. The Cardiovascular Nursing subtest is marked as "Core" in the official pattern, and Coronary Artery Disease, Angina and Myocardial Infarction appears in position 2nd of 4 in the NLE Cardiovascular Nursing review rotation. Passing mark: 75% weighted average with no sub-test below 60%. Recent NLE 2026 papers have drawn roughly 50 questions from this subject.

Coronary Artery Disease, Angina and Myocardial Infarction - Detailed Explanation

Cardiovascular disease is the leading cause of mortality in the Philippines, making Coronary Artery Disease (CAD), Angina, and Myocardial Infarction (MI) among the most critical and frequently tested topics in the NLE. The Department of Health (DOH) has prioritized non-communicable disease (NCD) prevention, including cardiovascular risk factor control, under programs like PhilPEN (Philippine Package of Essential NCD Interventions). As a future registered nurse under RA 9173 (Philippine Nursing Act of 2002), you are expected to apply the nursing process — from accurate assessment to timely, evidence-based interventions — to clients experiencing acute coronary events. This chapter covers CAD pathophysiology, the distinction between angina and MI, the modern approach to ACS management including the updated MONA framework, thrombolytic therapy, and cardiac rehabilitation. Mastery of these concepts is essential not only for the NLE board exam but for safe, competent clinical practice.

Concepts

Pathophysiology of Coronary Artery Disease (CAD)

Coronary Artery Disease (CAD) is the progressive narrowing and hardening of the coronary arteries — the blood vessels that supply oxygen-rich blood directly to the heart muscle (myocardium). The primary cause is ATHEROSCLEROSIS, a process where fatty, fibrous deposits called ATHEROMAS or PLAQUES build up inside the arterial wall (specifically the intima layer). Think of it like a water hose that gradually gets clogged with mineral deposits — over time, less and less water flows through. The pathophysiologic sequence is: (1) ENDOTHELIAL INJURY — the inner lining of the artery is damaged by factors like high blood pressure, smoking, or elevated blood glucose; (2) LDL DEPOSITION — low-density lipoprotein (LDL or 'bad cholesterol') seeps into the damaged intima; (3) INFLAMMATION — macrophages engulf LDL and become FOAM CELLS, forming a fatty streak; (4) PLAQUE FORMATION — smooth muscle cells migrate and form a fibrous cap over the lipid core, creating a stable plaque; (5) PLAQUE RUPTURE — an unstable plaque ruptures, exposing its core and triggering platelet aggregation and thrombus (blood clot) formation, which can PARTIALLY or COMPLETELY occlude the artery. When myocardial oxygen DEMAND exceeds oxygen SUPPLY, ISCHEMIA results. Prolonged complete occlusion leads to NECROSIS (cell death), which is the pathologic basis of Myocardial Infarction. Risk Factors are classified as MODIFIABLE (can be changed — hypertension, dyslipidemia, smoking, diabetes mellitus, obesity, physical inactivity, stress) and NON-MODIFIABLE (cannot be changed — age, male sex, family history, ethnicity). Women's risk increases significantly after menopause because estrogen's cardioprotective effect is lost. The DOH PhilPEN program screens for and manages these modifiable risk factors at the primary care level.

Examples

This scenario illustrates the importance of primary prevention in the Philippine healthcare setting. Under RA 9173, nurses have the independent function of health education and promotion. Identifying and addressing multiple risk factors is a priority nursing action at the community level.

Scenario

Mr. Santos, 55 years old, a known smoker with hypertension and a BMI of 32, presents to the rural health unit for PhilPEN screening. His fasting blood glucose is 180 mg/dL and his LDL is 180 mg/dL.

Solution

Mr. Santos has FOUR major modifiable risk factors for CAD: smoking, hypertension, obesity (BMI >30), and diabetes mellitus (elevated blood glucose). His high LDL further increases his risk. The nurse should counsel him on risk factor modification, refer for medical management of hypertension and diabetes, and provide health education on a heart-healthy diet and smoking cessation.

This tests understanding of the difference between stable (chronic, gradual narrowing) and unstable (acute rupture) atherosclerosis — a distinction directly relevant to understanding the spectrum from stable angina to ACS.

Scenario

A 62-year-old female patient tells the nurse: 'My doctor said I have plaque in my coronary arteries but my heart is still okay.' The nurse explains what could happen if a plaque ruptures.

Solution

The nurse explains that stable plaque can remain asymptomatic for years, but if it ruptures, the body forms a blood clot at the rupture site. This clot can suddenly block blood flow to the heart, causing a heart attack. This is why medication adherence and lifestyle modification are critical even without symptoms.

Applications

Use PhilPEN screening tools to identify patients at risk for CAD during community health visits.
Educate patients on the concept of 'silent' atherosclerosis — CAD can progress without symptoms for decades.
Apply the nursing process: Assess risk factors (Assessment) → Identify nursing diagnoses (Diagnosis) → Plan lifestyle modification education (Planning) → Implement teaching (Implementation) → Evaluate adherence (Evaluation).
Collaborate with physicians and community health workers for multi-disciplinary NCD management in barangay health centers.

Misconceptions

MISCONCEPTION: CAD only affects elderly males. CORRECTION: Women are also at significant risk, especially post-menopausal. Young adults with multiple risk factors can develop CAD.
MISCONCEPTION: If a patient has no chest pain, there is no CAD. CORRECTION: CAD can be SILENT — significant plaque can exist without symptoms, especially in diabetics.
MISCONCEPTION: High cholesterol is the only risk factor that matters. CORRECTION: CAD is multifactorial — smoking, hypertension, and diabetes are equally important risk factors.
MISCONCEPTION: HDL cholesterol causes CAD like LDL does. CORRECTION: HDL is PROTECTIVE (the 'good' cholesterol) and actually helps remove cholesterol from arteries.

Related Concepts

Angina Pectoris
Myocardial Infarction
Acute Coronary Syndrome
Hypertension Management
Dyslipidemia and Statin Therapy
DOH PhilPEN Program
Primary and Secondary Prevention

Common Exam Questions

Example

A patient with CAD is 68 years old, male, has a family history of MI, smokes 2 packs/day, and has a sedentary lifestyle. Which risk factors should the nurse focus teaching on? Answer: Smoking and sedentary lifestyle (modifiable).

Approach

Read the scenario and identify ALL risk factors present — count both modifiable and non-modifiable. The question may ask which risk factor the nurse should PRIORITIZE for teaching — always prioritize the MODIFIABLE ones since those can be changed.

Question Type

Risk Factor Identification

Example

Which event in atherosclerosis directly leads to acute coronary syndrome? Answer: Plaque rupture with subsequent thrombus formation.

Approach

Expect questions asking about the ORDER of events in atherosclerosis or which event TRIGGERS a specific outcome. Remember: Endothelial injury → LDL deposition → Inflammation → Plaque formation → Plaque rupture → Thrombus → ACS.

Question Type

Pathophysiology Sequence

Key Points To Remember

Atherosclerosis is the PRIMARY mechanism of CAD — endothelial injury leads to LDL deposition, inflammation, and plaque formation.
Plaque RUPTURE triggers thrombus formation, which causes Acute Coronary Syndrome (ACS).
Ischemia = reversible oxygen imbalance; Necrosis = irreversible cell death.
Modifiable risk factors are the TARGET of nursing health education and DOH NCD prevention programs.
Women's cardiovascular risk EQUALIZES after menopause due to loss of estrogen's protective effect.
LDL ('bad cholesterol') promotes atherosclerosis; HDL ('good cholesterol') is protective.
The nursing diagnosis applicable here includes: Ineffective Health Maintenance, Risk for Decreased Cardiac Tissue Perfusion, and Deficient Knowledge related to risk factor modification.

Angina Pectoris: Types, Assessment, and Management

Angina pectoris is chest pain or discomfort caused by TRANSIENT, REVERSIBLE myocardial ischemia. Unlike MI, the myocardium is NOT permanently damaged — it is temporarily starved of oxygen, causing pain, but the cells survive once perfusion is restored. Think of it like a muscle cramp: painful, but not causing permanent damage. CLASSIC ANGINAL PAIN is described as: substernal pressure, tightness, heaviness, or squeezing (patients often describe it as 'may kumukurot sa dibdib' or 'parang may nakapatong sa dibdib'). It typically RADIATES to the left arm, jaw, neck, shoulder, or back. It is usually accompanied by diaphoresis (cold sweat), dyspnea, and a sense of anxiety. THREE TYPES OF ANGINA: 1. STABLE (EXERTIONAL) ANGINA: The most common type. It is PREDICTABLE — triggered by physical exertion (climbing stairs, walking fast) or emotional stress, which increases myocardial oxygen DEMAND beyond what the narrowed arteries can supply. Key features: lasts 5–15 minutes, RELIEVED by rest and sublingual nitroglycerin (within 3–5 minutes). Cardiac biomarkers remain NORMAL because there is no cell death. ECG may show transient ST depression during pain but normalizes at rest. This is CHRONIC STABLE disease — the patient often knows their own pattern and trigger. 2. UNSTABLE ANGINA: This is an ACUTE CORONARY SYNDROME (ACS) — a medical emergency. It occurs at REST or with minimal exertion, is more frequent and severe than the patient's usual angina, and is NOT reliably relieved by rest or nitroglycerin. It signals that a plaque has become unstable or partially ruptured. CRITICAL DISTINCTION: Cardiac biomarkers (troponin, CK-MB) are NORMAL/NEGATIVE in unstable angina — this is what distinguishes it from NSTEMI. However, it still demands urgent evaluation and hospitalization. 3. VARIANT (PRINZMETAL'S) ANGINA: Caused by CORONARY ARTERY SPASM (not plaque), occurring at REST and typically at NIGHT. It is treated with calcium channel blockers and nitrates. Beta-blockers are generally avoided in vasospastic angina.

Examples

The hallmarks of stable angina are predictability, exertional trigger, brief duration, relief with rest and NTG, and NORMAL biomarkers. This is a classic NLE scenario that tests differentiation from MI.

Scenario

Mrs. Reyes, 60 years old, reports chest tightness whenever she walks up two flights of stairs. The pain goes away after 5 minutes of rest. This has been her pattern for 2 years. Her troponin levels are normal.

Solution

This is STABLE (EXERTIONAL) ANGINA. The pain is predictable (always with exertion), brief, relieved by rest, and cardiac biomarkers are normal. Management includes sublingual nitroglycerin PRN, long-acting nitrates, beta-blockers, aspirin, and lifestyle modification.

Any CHANGE in a patient's anginal pattern — more frequent, at rest, less responsive to NTG — signals unstable angina (ACS) and requires immediate emergency care. This is a high-priority NLE clinical judgment question.

Scenario

Mr. dela Cruz, who has known stable angina, calls the emergency room saying he has had chest pain three times today — once while resting and once while just watching TV. He took three nitroglycerin tablets but the pain only partially improved.

Solution

This presentation suggests a CHANGE in anginal pattern consistent with UNSTABLE ANGINA — it is now occurring at rest, is more frequent, and is not fully relieved by nitroglycerin. This is an ACS emergency. He must be brought to the hospital immediately for evaluation, ECG, and cardiac biomarkers.

Applications

Teach stable angina patients to recognize their triggers and carry sublingual nitroglycerin at all times.
Instruct patients on correct NTG use: sit down first, place 1 tablet under the tongue, repeat every 5 minutes up to 3 doses; call emergency services if pain persists after 5 minutes.
Differentiate stable vs. unstable angina using: pattern change, pain at rest, inadequate NTG response — these require immediate hospital transfer.
In a Philippine community setting (barangay health center), a patient with NEW onset chest pain at rest must be referred to a secondary or tertiary hospital immediately.
Monitor for NTG side effects: headache (most common — due to vasodilation), hypotension, and dizziness.

Misconceptions

MISCONCEPTION: Unstable angina has elevated troponin. CORRECTION: Troponin is NORMAL in unstable angina. Elevated troponin means NSTEMI (actual necrosis has occurred).
MISCONCEPTION: If nitroglycerin relieves the pain, it must not be serious. CORRECTION: Even if NTG partially relieves pain, any angina occurring at rest or with a changed pattern is still an emergency requiring evaluation.
MISCONCEPTION: Variant angina is the same as stable angina. CORRECTION: Variant (Prinzmetal's) angina is caused by coronary SPASM — it occurs at REST and at NIGHT, and is treated differently (calcium channel blockers, not beta-blockers).
MISCONCEPTION: Stable angina means the patient's heart is not at risk. CORRECTION: Stable angina indicates significant underlying CAD. Without treatment, it can progress to ACS at any time.

Related Concepts

Myocardial Infarction
Acute Coronary Syndrome
Nitroglycerin Pharmacology
ECG Interpretation Basics
Troponin and Cardiac Biomarkers

Common Exam Questions

Example

A patient reports chest pain at rest that is not relieved by 3 doses of sublingual nitroglycerin. Troponin is negative. What type of angina is this? Answer: Unstable angina.

Approach

Focus on THREE key differentiating features: (1) When does it occur? (exertion vs. rest), (2) How is it relieved? (rest/NTG vs. not relieved), (3) Biomarkers normal or elevated? (both anginas have NORMAL biomarkers — but MI has elevated ones).

Question Type

Differentiation — Stable vs. Unstable Angina

Example

A patient with known angina reports sudden chest pain. What is the nurse's PRIORITY action? Answer: Assess the pain characteristics (PQRST) and obtain a 12-lead ECG immediately.

Approach

For a patient with chest pain, the PRIORITY is always to assess the pain first, then perform/obtain a 12-lead ECG within 10 minutes, establish IV access, and administer medications as ordered. ABCs first, then ECG.

Question Type

Priority Nursing Action

Example

A patient asks how many nitroglycerin tablets she can take for chest pain. The nurse correctly responds: Up to 3 tablets, one every 5 minutes, and to call for help immediately if pain is not relieved.

Approach

NLE frequently tests NTG administration: sublingual route, maximum 3 doses 5 minutes apart, check BP before each dose, contraindicated in hypotension.

Question Type

Nitroglycerin Teaching

Key Points To Remember

Angina = REVERSIBLE ischemia — NO myocardial necrosis, normal cardiac biomarkers.
Stable angina is PREDICTABLE: triggered by exertion/stress, relieved by rest and nitroglycerin within 5 minutes.
Unstable angina = ACS emergency: occurs at rest, NOT relieved by nitro, but biomarkers are STILL NORMAL (key differentiator from NSTEMI).
Variant (Prinzmetal's) angina = caused by coronary SPASM, not plaque — occurs at rest, treated with calcium channel blockers.
Nitroglycerin mechanism: vasodilates coronary and peripheral vessels → reduces preload and myocardial oxygen demand → relieves ischemic pain.
The NANDA nursing diagnosis for angina: Acute Pain related to myocardial ischemia; Activity Intolerance related to imbalance between oxygen supply and demand.

Myocardial Infarction (MI): Assessment, Diagnosis, and Manifestations

Myocardial Infarction (MI) — commonly known as a heart attack — is the IRREVERSIBLE DEATH (NECROSIS) of myocardial tissue due to PROLONGED, COMPLETE interruption of blood supply to a portion of the heart. The key phrase is 'TIME IS MUSCLE' — for every minute the coronary artery remains blocked, more heart muscle cells die. A typical MI destroys thousands of heart cells per second. This is why rapid recognition and intervention are life-saving. PATHOPHYSIOLOGY: A ruptured atherosclerotic plaque triggers platelet aggregation and thrombus formation that COMPLETELY occludes a coronary artery. The zone of injury progresses in zones: the central INFARCT (necrotic, permanently dead) is surrounded by a zone of INJURY (severely ischemic, may be salvageable) and an outer zone of ISCHEMIA (mildly ischemic, reversible). This is why rapid reperfusion therapy can SAVE the surrounding zones even if the central infarct is irreversible. TYPES BASED ON ECG: - STEMI (ST-Elevation MI): COMPLETE coronary occlusion causing full-thickness (transmural) injury. ECG shows ST-segment ELEVATION. This is the most urgent emergency — immediate reperfusion is mandatory. - NSTEMI (Non-ST-Elevation MI): PARTIAL occlusion causing subendocardial injury. ECG shows ST depression or T-wave inversion (NOT elevation). Troponin is ELEVATED, confirming necrosis. CLASSIC MANIFESTATIONS OF MI: - CHEST PAIN: Severe, crushing, substernal, described as 'heavy pressure' or 'elephant sitting on chest' (or 'parang may humahamak sa dibdib'). Lasts MORE THAN 20–30 MINUTES and is NOT relieved by rest or nitroglycerin. - RADIATION: Left arm, jaw, neck, shoulder, back, or epigastric area. - AUTONOMIC SIGNS: Diaphoresis (profuse cold sweating), nausea, vomiting, pallor. - OTHER: Dyspnea, palpitations, hypotension, cool/clammy skin, extreme anxiety, and a SENSE OF IMPENDING DOOM (angor animi) — this is a classic NLE item. ATYPICAL PRESENTATIONS (HIGHLY TESTED): Women, older adults, and people with DIABETES (due to autonomic neuropathy causing decreased pain sensation) may present WITHOUT classic chest pain. Instead, they may have: fatigue, shortness of breath, indigestion or epigastric discomfort, jaw pain, back pain, or nausea/vomiting. SILENT MI — completely painless infarction — is most common in DIABETICS. DIAGNOSTICS: - 12-LEAD ECG: Must be obtained within 10 MINUTES of presentation. ST elevation in 2 or more contiguous leads = STEMI. Pathologic Q waves develop LATER (hours to days) and indicate completed infarction. - CARDIAC BIOMARKERS: TROPONIN (I or T) is the MOST SPECIFIC AND SENSITIVE marker for myocardial necrosis. It rises within 3–4 hours, peaks at 24 hours, and may remain elevated for 10–14 days. CK-MB (Creatine Kinase MB isoenzyme) is also elevated but less specific; it rises within 3–6 hours and returns to normal in 2–3 days. Serial troponins (drawn at presentation, 3 hours, and 6 hours) are used to confirm MI. - TROPONIN IS THE GOLD STANDARD — if troponin is elevated in the context of ischemic symptoms or ECG changes, this CONFIRMS MI.

Examples

This is a high-yield NLE scenario combining ECG interpretation, MI localization, and priority nursing interventions. Note the CAUTION with NTG in inferior MI — this is a commonly tested nuance.

Scenario

Mr. Gomez, 58 years old, presents to the emergency room with severe substernal chest pain radiating to his left arm for the past 45 minutes. He is diaphoretic, pale, and says 'pakiramdam ko, mamamatay na ako.' His ECG shows ST elevation in leads II, III, and aVF. His troponin is pending.

Solution

This is a STEMI — specifically an INFERIOR STEMI (ST elevation in leads II, III, aVF indicates the right coronary artery territory). The nurse should immediately: (1) call the physician/activate the cath lab, (2) obtain IV access, (3) administer chewable aspirin 325 mg, (4) prepare for nitroglycerin — BUT FIRST check BP (inferior STEMI has high risk of right ventricular infarction and hypotension; NTG is relatively contraindicated), (5) initiate continuous cardiac monitoring.

This scenario tests understanding of atypical MI presentations in women and diabetics. In diabetics, autonomic neuropathy impairs pain sensation, leading to 'silent' or atypical MI. The nurse must suspect MI even WITHOUT chest pain in high-risk patients with unexplained fatigue, dyspnea, or indigestion.

Scenario

Mrs. Tan, 68 years old, a known diabetic, comes to the clinic saying she has felt 'extremely tired and short of breath' for the past day. She denies chest pain. Her ECG shows new T-wave inversions and her troponin is 2.5 ng/mL (elevated).

Solution

This is an ATYPICAL MI presentation — specifically NSTEMI — in a diabetic woman. Despite the absence of classic chest pain, elevated troponin and ECG changes confirm myocardial necrosis. She should be admitted immediately for further management.

Applications

Implement the 'Chest Pain Protocol': ECG within 10 minutes, IV access, continuous monitoring, stat cardiac biomarkers, aspirin administration.
When a patient says 'pakiramdam ko, mamamatay na ako' (sense of impending doom), treat this as a serious cardiac symptom and escalate care immediately.
Educate community members to call emergency services (911 or local emergency number) for chest pain lasting more than 5 minutes — do NOT drive yourself to the hospital.
Be alert for atypical presentations in your high-risk Filipino patients: middle-aged to elderly women, all diabetics, and elderly patients who may present with only fatigue or dyspnea.
Document ECG findings accurately and report ST changes immediately to the physician — this directly impacts the decision for reperfusion therapy.

Misconceptions

MISCONCEPTION: MI always presents with severe chest pain. CORRECTION: Atypical presentations are common in women, elderly, and diabetics — SILENT MI is possible without any pain.
MISCONCEPTION: A normal ECG rules out MI. CORRECTION: NSTEMI may not show ST elevation; only elevated troponin (with clinical context) confirms the diagnosis.
MISCONCEPTION: Q waves on ECG appear immediately during MI. CORRECTION: Pathologic Q waves develop HOURS TO DAYS after the MI — they are a LATE finding indicating completed infarction.
MISCONCEPTION: CK-MB is the best biomarker for MI. CORRECTION: TROPONIN (I or T) is the gold standard — it is more specific and sensitive. CK-MB is useful for detecting REINFARCTION (it normalizes faster and can re-elevate).
MISCONCEPTION: NSTEMI is not as dangerous as STEMI. CORRECTION: NSTEMI still involves actual myocardial necrosis (elevated troponin) and carries significant morbidity and mortality risk.

Related Concepts

Angina Pectoris
Acute Coronary Syndrome Management
MONA Framework
Reperfusion Therapy (PCI and Thrombolytics)
Cardiac Complications (VFib, Cardiogenic Shock)
ECG Interpretation
Cardiac Rehabilitation

Common Exam Questions

Example

A patient's chest pain has lasted 35 minutes and three nitroglycerin tablets gave no relief. Troponin is 3.2 ng/mL. What condition is this? Answer: Myocardial Infarction.

Approach

The three KEY differentiators are: (1) Duration — MI lasts >20-30 minutes; (2) Relief — MI NOT relieved by rest/NTG; (3) Biomarkers — MI has ELEVATED troponin and CK-MB. Memorize the comparison table.

Question Type

Differentiation — Angina vs. MI

Example

Which cardiac biomarker is the MOST SPECIFIC indicator of myocardial necrosis? Answer: Troponin (I or T).

Approach

Know the order: Troponin rises at 3-4 hours, peaks at 24 hours, persists for 10-14 days. CK-MB rises at 3-6 hours, returns to normal in 2-3 days. Troponin is MORE SPECIFIC for myocardial injury.

Question Type

Cardiac Biomarker Knowledge

Example

A 65-year-old diabetic woman reports severe indigestion and unusual fatigue for 2 hours. No chest pain. What is the nurse's priority? Answer: Obtain a 12-lead ECG immediately and draw cardiac biomarkers (suspect atypical MI presentation).

Approach

When the NLE scenario describes a woman, elderly, or diabetic patient with NON-SPECIFIC symptoms (fatigue, dyspnea, indigestion, jaw pain) — THINK MI. The question may ask what the nurse should do next.

Question Type

Atypical Presentation Recognition

Key Points To Remember

MI = IRREVERSIBLE NECROSIS — 'Time is Muscle': every minute of occlusion = more dead myocardium.
Classic MI pain: severe, crushing, substernal, lasts >20-30 minutes, NOT relieved by rest or nitroglycerin.
STEMI = complete occlusion, ST ELEVATION on ECG → needs IMMEDIATE reperfusion.
NSTEMI = partial occlusion, ST depression/T-wave inversion, but ELEVATED TROPONIN confirms necrosis.
TROPONIN is the GOLD STANDARD cardiac biomarker — most specific and sensitive for MI.
Atypical presentations (women, elderly, diabetics): fatigue, dyspnea, indigestion — NO classic chest pain.
Obtain 12-lead ECG within 10 MINUTES of presentation — this is a benchmark quality indicator.
'Sense of impending doom' (angor animi) is a CLASSIC MI finding — take it seriously.
Silent MI (painless) occurs in DIABETICS due to autonomic neuropathy.

Acute Coronary Syndrome Management: The Updated MONA Framework

Acute Coronary Syndrome (ACS) is an umbrella term covering UNSTABLE ANGINA, NSTEMI, and STEMI. The goal of immediate management is to RELIEVE PAIN, RESTORE PERFUSION, and PREVENT COMPLICATIONS AND DEATH. The mnemonic MONA (Morphine, Oxygen, Nitroglycerin, Aspirin) has traditionally guided initial ACS management. HOWEVER, current evidence-based practice has SIGNIFICANTLY REFINED this approach. The NLE increasingly tests this modern nuance, so understanding WHEN and WHY each drug is used (or withheld) is critical. --- A: ASPIRIN --- ASPIRIN (chewable, 160-325 mg) is the FIRST PRIORITY DRUG in ACS. It IRREVERSIBLY inhibits cyclooxygenase (COX), reducing thromboxane A2 production, thereby inhibiting platelet aggregation. Giving aspirin EARLY has been shown to REDUCE MORTALITY in MI. Key teaching: it must be CHEWED (not swallowed whole) to achieve faster absorption and more rapid platelet inhibition. Give immediately unless the patient has a true aspirin allergy or active gastrointestinal bleeding. --- N: NITROGLYCERIN --- Nitroglycerin (NTG) is a potent VASODILATOR. It dilates coronary arteries (increases oxygen SUPPLY) and peripheral veins (reduces preload, decreasing oxygen DEMAND). Given sublingually: 0.3-0.4 mg every 5 minutes, UP TO 3 DOSES, checking blood pressure between each dose. CRITICAL CONTRAINDICATIONS (highly NLE-tested): 1. HYPOTENSION (systolic BP below 90 mmHg) — NTG lowers BP further, leading to dangerous hypotension and shock. 2. RIGHT VENTRICULAR / INFERIOR MI — the right ventricle depends on PRELOAD to maintain output; NTG reduces preload and can cause profound hypotension. Always suspect RV involvement in INFERIOR STEMI (ST elevation in II, III, aVF). 3. RECENT USE OF PHOSPHODIESTERASE INHIBITORS (sildenafil/Viagra, tadalafil/Cialis) within 24-48 hours — combining these with NTG causes life-threatening, refractory hypotension. --- O: OXYGEN --- OXYGEN is now given ONLY IF THE PATIENT IS HYPOXIC — specifically, when SpO₂ is BELOW 90-94%. ROUTINE oxygen supplementation in a patient with normal oxygen saturation is NO LONGER RECOMMENDED. Research shows that hyperoxia (excessive oxygen) in normoxic MI patients may paradoxically WORSEN outcomes by causing coronary vasoconstriction and increasing oxidative stress. This is a modern NLE nuance that contradicts older practice. When in doubt: check SpO₂ first! --- M: MORPHINE --- MORPHINE is an opioid analgesic that relieves pain, reduces anxiety, and decreases sympathetically-driven increases in heart rate and blood pressure — all of which reduce myocardial oxygen DEMAND. HOWEVER, morphine is now RESERVED for pain NOT RELIEVED by nitroglycerin. When overused, morphine may: (1) mask ongoing ischemic pain, delaying recognition of continued infarction, (2) slow gastric absorption of oral medications (like aspirin), and (3) cause respiratory depression and hypotension. Monitor respiratory status and blood pressure after administration. THE MODERN PRIORITY ORDER: Current ACS management prioritizes: ASPIRIN FIRST → nitroglycerin for pain → reperfusion therapy → oxygen only for hypoxia → morphine only for refractory pain. REPERFUSION (PCI or thrombolytics) is the cornerstone of STEMI management.

Examples

This scenario tests the modern MONA nuance. Even if NTG and O2 are ordered, the nurse must recognize contraindications and use clinical judgment. Administering NTG to a hypotensive patient could cause cardiovascular collapse.

Scenario

A 52-year-old male with STEMI presents to the ER. BP is 88/60 mmHg, SpO₂ is 98%. He is in severe chest pain. The physician orders MONA. Which component should the nurse QUESTION or modify?

Solution

The nurse should WITHHOLD NITROGLYCERIN (BP is 88/60 mmHg — severe hypotension is a contraindication) and withhold supplemental OXYGEN (SpO₂ is 98% — patient is not hypoxic). The nurse should administer ASPIRIN immediately, report the hypotension to the physician (may indicate cardiogenic shock or RV infarction), and prepare for emergency PCI.

This is a real clinical scenario that also appears in NLE exams. Part of nursing assessment is asking about ALL medications, including those the patient may be embarrassed to mention. Under RA 9173, comprehensive assessment is within the scope of nursing practice.

Scenario

A patient with chest pain admits to taking sildenafil (Viagra) 6 hours ago for erectile dysfunction. He now has chest pain consistent with ACS.

Solution

Nitroglycerin is ABSOLUTELY CONTRAINDICATED in this patient due to recent sildenafil use (within 24 hours). The combination of NTG and PDE5 inhibitors can cause severe, refractory hypotension. Report to physician immediately. Aspirin should still be given. Pain management should use alternative approaches.

Applications

Before giving nitroglycerin: ALWAYS assess blood pressure and ask about recent PDE5 inhibitor use (sildenafil, tadalafil, vardenafil).
Before giving oxygen: Check SpO₂ with pulse oximetry — oxygen therapy is evidence-based and should be titrated, not given routinely.
Administer chewable aspirin FIRST in any ACS patient unless genuinely contraindicated (true allergy, active GI bleeding).
Educate patients that aspirin in ACS should be CHEWED, not swallowed, for faster absorption.
Morphine use requires monitoring: respiratory rate, BP, and level of consciousness post-administration.

Misconceptions

MISCONCEPTION: MONA should always be given in full to every ACS patient. CORRECTION: Each component has specific indications and contraindications — clinical judgment is required.
MISCONCEPTION: Oxygen should always be given to patients with MI. CORRECTION: Evidence shows routine oxygen in normoxic patients may be harmful. Give ONLY if SpO₂ < 90-94%.
MISCONCEPTION: Morphine should be given immediately for MI pain. CORRECTION: Morphine is now RESERVED for pain not controlled by nitroglycerin due to potential masking of ischemia.
MISCONCEPTION: Aspirin should be swallowed whole to avoid stomach upset. CORRECTION: In ACS, aspirin must be CHEWED for rapid absorption and immediate platelet inhibition.
MISCONCEPTION: It is safe to give NTG after the patient took Viagra yesterday. CORRECTION: NTG is contraindicated within 24 hours of sildenafil use and 48 hours of tadalafil use.

Related Concepts

Reperfusion Therapy (PCI and Thrombolytics)
Angina Pectoris and NTG Use
Adjunct Pharmacology (Antiplatelets, Anticoagulants, Beta-blockers)
Cardiac Monitoring and Dysrhythmias
STEMI vs. NSTEMI Management Differences

Common Exam Questions

Example

A patient presents with acute MI. Which medication should be administered FIRST? Answer: Chewable Aspirin 160-325 mg.

Approach

The NLE may ask what the FIRST drug to give is in ACS. Answer: ASPIRIN (chewed). It is the highest priority because of its mortality benefit and rapid action when chewed.

Question Type

Priority Drug in ACS

Example

A patient with chest pain has a BP of 85/55 mmHg. The nurse is about to give sublingual NTG. What should the nurse do? Answer: WITHHOLD nitroglycerin — hypotension is a contraindication. Report to physician.

Approach

Identify which scenario makes NTG contraindicated: look for (1) hypotension in the vital signs, (2) inferior/RV MI pattern on ECG, or (3) mention of recent sildenafil/tadalafil use.

Question Type

NTG Contraindication Identification

Example

An MI patient has an SpO₂ of 97% on room air. Should the nurse apply supplemental oxygen? Answer: No — routine oxygen is not indicated for normoxic patients; it may be harmful.

Approach

The NLE may present a scenario where a patient with MI has a SpO₂ of 96-98% and ask if oxygen should be given. Modern evidence says NO — oxygen is only given for hypoxia (SpO₂ < 90-94%).

Question Type

Oxygen Therapy — Modern Evidence

Key Points To Remember

ASPIRIN is the FIRST PRIORITY DRUG — chewed (not swallowed), 160-325 mg, reduces platelet aggregation and mortality.
OXYGEN: Give ONLY if SpO₂ < 90-94% — routine oxygen in normoxic patients is NO LONGER recommended.
NITROGLYCERIN: Up to 3 sublingual doses, every 5 minutes — CHECK BP before each dose.
NTG is CONTRAINDICATED in: (1) Hypotension, (2) Right ventricular/Inferior MI, (3) Recent phosphodiesterase inhibitor use (sildenafil).
MORPHINE: Reserve for pain NOT relieved by nitroglycerin — can mask ischemia and has been associated with worse outcomes if overused.
Modern MONA order in practice: ASPIRIN → NTG → O2 (if hypoxic) → Morphine (if needed).
The PRIMARY goal in STEMI is RAPID REPERFUSION — PCI (door-to-balloon < 90 min) or thrombolytics (door-to-needle < 30 min).

Reperfusion Therapy: PCI and Thrombolytics

REPERFUSION THERAPY is the cornerstone of STEMI management. The goal is to REOPEN THE BLOCKED CORONARY ARTERY as quickly as possible to salvage the ischemic but still-viable myocardium surrounding the central infarct zone. The phrase 'TIME IS MUSCLE' cannot be overemphasized — every 30 minutes of delay results in significantly worse outcomes. TWO MAIN REPERFUSION STRATEGIES: 1. PERCUTANEOUS CORONARY INTERVENTION (PCI) — THE PREFERRED METHOD: PCI (also known as PTCA with stenting or 'balloon angioplasty with stent') involves threading a catheter through the femoral or radial artery to the blocked coronary artery, inflating a balloon to compress the plaque, and placing a stent to keep the artery open. PCI is the GOLD STANDARD reperfusion for STEMI when immediately available. KEY TIME METRIC: DOOR-TO-BALLOON TIME < 90 MINUTES — from the time the patient arrives at the hospital ('door') to the time the balloon is inflated in the artery ('balloon'). This is a critical quality indicator in cardiac care. In the Philippine setting, PCI is available primarily in major tertiary hospitals in Metro Manila and urban centers. 2. THROMBOLYTIC (FIBRINOLYTIC) THERAPY — WHEN PCI IS UNAVAILABLE: Thrombolytics are drugs that DISSOLVE THE CLOT by activating plasminogen, which breaks down fibrin in the thrombus. Examples: ALTEPLASE (tPA), RETEPLASE, TENECTEPLASE (all recombinant tissue plasminogen activators), and STREPTOKINASE (older, less clot-specific). These are used when TIMELY PCI is unavailable — a critical consideration in the Philippine rural healthcare context where many patients are far from catheterization laboratories. KEY TIME METRIC: DOOR-TO-NEEDLE TIME < 30 MINUTES — from arrival to drug administration. Thrombolytics are MOST EFFECTIVE within the FIRST 6 HOURS of symptom onset and can be given up to 12 hours. IMPORTANT: Thrombolytics are used in STEMI (complete occlusion) but are CONTRAINDICATED/NOT BENEFICIAL in NSTEMI (partial occlusion) — there is no complete thrombus to dissolve, and the risk of bleeding without clear benefit makes this inappropriate. THROMBOLYTIC NURSING CONSIDERATIONS (HIGH-YIELD NLE TOPIC): MAJOR RISK: BLEEDING — including potentially fatal INTRACRANIAL HEMORRHAGE. The nurse's primary concern post-thrombolytic administration is bleeding assessment. ABSOLUTE CONTRAINDICATIONS TO THROMBOLYTICS: - Active internal bleeding (excluding menstruation) - History of HEMORRHAGIC STROKE (any time) - Recent ISCHEMIC STROKE within 3 months - Intracranial neoplasm, arteriovenous malformation, or aneurysm - Recent major surgery or trauma (within 3 months) - Severe, uncontrolled hypertension (BP > 180/110 mmHg) POST-THROMBOLYTIC NURSING CARE: - Monitor for bleeding: check urine (hematuria), stools (melena), IV sites, neurologic status (signs of intracranial bleeding — sudden headache, confusion, unequal pupils). - MINIMIZE INVASIVE PROCEDURES — limit unnecessary venipunctures, do NOT give IM injections, avoid arterial punctures at non-compressible sites. - APPLY PRESSURE to all puncture sites for 10-15 minutes. - Monitor for REPERFUSION SIGNS: (1) Relief of chest pain, (2) Return of ST segment toward baseline on ECG, (3) Reperfusion dysrhythmias (accelerated idioventricular rhythm — a sign the artery has reopened, usually benign and transient), (4) Peak of CK-MB earlier than expected. - Report any signs of bleeding immediately.

Examples

This scenario is highly relevant to the Philippine healthcare context where many patients in Visayas, Mindanao, and rural Luzon do not have immediate access to PCI-capable hospitals. Understanding thrombolytic therapy is critical for nurses in these settings.

Scenario

Mr. Bautista arrives at a provincial hospital with STEMI symptoms for 90 minutes. The nearest cath lab is 4 hours away. His BP is 140/90 mmHg, no history of stroke, no recent surgery. He is otherwise a candidate for thrombolytic therapy.

Solution

Since PCI is not accessible within the 90-minute window, THROMBOLYTIC THERAPY is indicated. The nurse should: (1) confirm no absolute contraindications, (2) administer thrombolytic within 30 minutes of arrival (door-to-needle < 30 min), (3) establish IV access and draw baseline labs (CBC, PT/aPTT), (4) post-administration: minimize invasive procedures, monitor for bleeding and neurologic changes, monitor ECG for reperfusion signs.

Recognizing reperfusion signs is an important post-thrombolytic nursing competency. The nurse must distinguish benign reperfusion dysrhythmias from dangerous ventricular tachycardia or fibrillation requiring immediate intervention.

Scenario

After receiving alteplase, Mr. Bautista's chest pain resolves, his ECG shows ST segments returning toward baseline, and a brief run of accelerated idioventricular rhythm appears on the monitor. The nurse notes these changes.

Solution

These are REPERFUSION SIGNS — indicators that the thrombolytic therapy is working and the coronary artery has reopened. The accelerated idioventricular rhythm in this context is a BENIGN REPERFUSION DYSRHYTHMIA — usually transient and does not require antiarrhythmic treatment. The nurse should continue monitoring and report findings to the physician.

Applications

In any STEMI scenario, the nurse must immediately activate the reperfusion protocol and communicate ECG findings to the physician.
Before administering thrombolytics, SCREEN the patient thoroughly for absolute contraindications — this is a nursing responsibility under RA 9173.
Post-thrombolytic administration: Hold non-essential venipunctures. If IV access must be obtained, use the smallest gauge needed and apply firm pressure for at least 10-15 minutes.
Document and report any neurological changes (sudden headache, change in level of consciousness, pupil inequality) immediately — these may indicate intracranial hemorrhage.
Educate community members to go to the NEAREST HOSPITAL capable of reperfusion therapy immediately when chest pain starts — time saved equals myocardium saved.

Misconceptions

MISCONCEPTION: Thrombolytics can be used for NSTEMI too. CORRECTION: Thrombolytics are ONLY for STEMI (complete occlusion). In NSTEMI, there is only partial occlusion, and thrombolytics offer no benefit but carry significant bleeding risk.
MISCONCEPTION: Reperfusion dysrhythmias after thrombolytics are always dangerous. CORRECTION: ACCELERATED IDIOVENTRICULAR RHYTHM after thrombolytics is a BENIGN SIGN OF SUCCESSFUL REPERFUSION — it does not require antiarrhythmic treatment.
MISCONCEPTION: Any history of stroke contraindicates thrombolytics. CORRECTION: HEMORRHAGIC stroke at any time is absolute contraindication. ISCHEMIC stroke within 3 months is a contraindication; beyond 3 months, it is a relative contraindication requiring physician judgment.
MISCONCEPTION: PCI is available everywhere in the Philippines. CORRECTION: PCI is primarily available in major tertiary hospitals in urban centers. Rural and provincial nurses must be competent in thrombolytic therapy.
MISCONCEPTION: Thrombolytics work up to 24 hours. CORRECTION: Thrombolytics are MOST EFFECTIVE within 6 hours of symptom onset; they can be given up to 12 hours but with diminishing benefit.

Related Concepts

STEMI vs. NSTEMI Classification
Anticoagulation (Heparin) post-reperfusion
Cardiac Catheterization Nursing Care
Dysrhythmia Recognition (VFib, AIVR)
Philippine Tertiary Hospital Capabilities and Referral System

Common Exam Questions

Example

A STEMI patient presents to a hospital without a cardiac catheterization lab. What reperfusion therapy should be administered? Answer: Thrombolytic therapy (e.g., alteplase) — administer within 30 minutes of arrival.

Approach

The NLE may present a scenario and ask which reperfusion is preferred or which is used in a specific context. Rule: PCI = preferred when available within 90 min. Thrombolytics = when PCI unavailable and within 6-12 hours of onset.

Question Type

Choice of Reperfusion Therapy

Example

A STEMI patient had a hemorrhagic stroke 18 months ago. Is thrombolytic therapy appropriate? Answer: NO — prior hemorrhagic stroke is an ABSOLUTE contraindication regardless of when it occurred.

Approach

Read the scenario for any ABSOLUTE contraindication: stroke history, recent surgery, active bleeding, intracranial problem, uncontrolled hypertension. If any are present, thrombolytics should NOT be given.

Question Type

Thrombolytic Contraindication

Example

After receiving streptokinase, what is the nurse's PRIORITY intervention? Answer: Monitor for bleeding — avoid unnecessary invasive procedures, apply pressure to puncture sites, assess neurologic status.

Approach

Focus on BLEEDING PREVENTION AND DETECTION. Priority actions: minimize venipunctures, no IM injections, apply pressure to all puncture sites, monitor neurologic status and urine/stool for bleeding.

Question Type

Post-Thrombolytic Nursing Priorities

Key Points To Remember

PCI is the PREFERRED (first-line) reperfusion for STEMI — door-to-balloon time < 90 MINUTES.
Thrombolytics are used when TIMELY PCI is UNAVAILABLE — door-to-needle < 30 MINUTES, within 6-12 hours of symptom onset.
Thrombolytics are for STEMI ONLY — NOT used in NSTEMI or unstable angina.
The MAJOR RISK of thrombolytics is BLEEDING, especially INTRACRANIAL HEMORRHAGE.
ABSOLUTE CONTRAINDICATIONS: prior hemorrhagic stroke, recent ischemic stroke (<3 months), active internal bleeding, intracranial neoplasm, recent major surgery/trauma, severe uncontrolled hypertension.
Post-thrombolytic nursing priorities: MINIMIZE invasive procedures, monitor for bleeding (neuro status, urine, stool, IV sites), watch for reperfusion signs.
REPERFUSION DYSRHYTHMIAS (e.g., accelerated idioventricular rhythm) after thrombolytics = SIGN OF SUCCESSFUL REPERFUSION — usually benign and transient.
In the Philippines, PCI availability is limited to major tertiary centers — thrombolytics remain clinically relevant in rural/provincial settings.

Adjunct Pharmacology, Complications, and Cardiac Rehabilitation

ADJUNCT PHARMACOLOGY IN ACS: 1. DUAL ANTIPLATELET THERAPY (DAPT): Aspirin PLUS a P2Y12 inhibitor — CLOPIDOGREL (Plavix), TICAGRELOR, or PRASUGREL. These drugs block platelet aggregation through complementary mechanisms, reducing re-thrombosis after stenting or thrombolytics. Teach patients: do NOT stop antiplatelets without physician approval, especially after PCI stenting — abrupt discontinuation can cause in-stent thrombosis. 2. ANTICOAGULANTS: HEPARIN (unfractionated UFH or low-molecular-weight heparin/LMWH such as enoxaparin/Clexane) prevents clot PROPAGATION (extension of the existing clot). UFH requires aPTT monitoring (target: 1.5-2.5 times control). LMWH (enoxaparin) has more predictable dosing, does not routinely require aPTT monitoring, and is given subcutaneously. 3. BETA-BLOCKERS (metoprolol, atenolol): Reduce heart rate, blood pressure, and myocardial oxygen demand. Begin early unless contraindicated (bradycardia, hypotension, bronchospasm/severe asthma, acute decompensated heart failure). 4. ACE INHIBITORS (lisinopril, enalapril): Reduce afterload, prevent ventricular remodeling (fibrosis and dilation post-MI), and reduce mortality. Monitor for: persistent cough (most common side effect), hyperkalemia, and hypotension. Start within 24 hours of MI if the patient is hemodynamically stable. 5. STATINS (atorvastatin, rosuvastatin): HIGH-INTENSITY statin therapy is started early in ACS regardless of baseline cholesterol level — statins stabilize plaque, reduce inflammation, and lower LDL. Monitor for myalgia/muscle pain (risk of RHABDOMYOLYSIS — rare but serious) and elevated liver enzymes. MI COMPLICATIONS: The nurse must continuously MONITOR for these complications: - DYSRHYTHMIAS: The MOST COMMON early complication. VENTRICULAR FIBRILLATION is the LEADING CAUSE OF DEATH in the FIRST HOURS of MI — this is why continuous cardiac monitoring is MANDATORY. Other dysrhythmias: ventricular tachycardia, complete heart block (especially in inferior MI). - CARDIOGENIC SHOCK: Severe pump failure — hypotension, poor peripheral perfusion, oliguria, altered mental status. Medical emergency requiring vasopressors and IABP. - HEART FAILURE AND PULMONARY EDEMA: The damaged myocardium pumps less effectively — fluid backs up into the lungs. Signs: dyspnea, crackles, frothy sputum, S3 heart sound. - PERICARDITIS: Inflammation of the pericardium, occurring 1-3 days post-MI. Chest pain aggravated by INSPIRATION (pleuritic) and POSITION (worse lying down, better sitting forward). Friction rub on auscultation. - DRESSLER'S SYNDROME: A delayed autoimmune pericarditis occurring 2-10 WEEKS post-MI. Treated with NSAIDs or aspirin. - VENTRICULAR ANEURYSM AND CARDIAC RUPTURE: Late complications of large MIs. CARDIAC REHABILITATION: Cardiac rehabilitation (Cardiac Rehab) is a comprehensive, structured program with THREE PHASES: - PHASE I (INPATIENT): Begins in the hospital — passive range of motion, dangling at bedside, short supervised walks. Goal: prevent deconditioning, monitor response to activity. - PHASE II (EARLY OUTPATIENT/SUPERVISED): 4-12 weeks of supervised exercise, education, and risk factor modification in a monitored clinic setting. - PHASE III (LONG-TERM MAINTENANCE): Ongoing home exercise program and lifestyle changes. KEY PATIENT TEACHING POINTS FOR DISCHARGE: - NITROGLYCERIN: Sit down before taking; place one tablet under tongue; repeat every 5 minutes up to 3 doses; call emergency services (911) if pain persists after the first dose or 5 minutes. STORE in a dark, airtight, cool container — NOT in a pocket close to the body (heat degrades it). - RECOGNIZE WARNING SIGNS: Return to ER for chest pain lasting >5 minutes, new shortness of breath, syncope, palpitations. - RISK FACTOR MODIFICATION: STOP SMOKING (single most important intervention), control BP and blood sugar, heart-healthy diet (low saturated fat, low sodium), regular exercise, stress management. - MEDICATIONS: Adhere to all medications — especially antiplatelets (clopidogrel/aspirin); NEVER stop without physician guidance. - ACTIVITY RESUMPTION: Follow physician guidance for return to work, driving (usually 1-2 weeks for uncomplicated MI), and sexual activity.

Examples

Differentiating post-MI pericarditis from RECURRENT MI is a critical clinical judgment skill tested on the NLE. Key clue: POSITIONAL and PLEURITIC nature of pain (unlike MI which is not positional), plus friction rub on auscultation.

Scenario

Mr. Ramos, 3 days post-MI, develops sharp chest pain that worsens when he lies flat and improves when he leans forward. The nurse auscultates a friction rub.

Solution

These findings are classic for POST-MI PERICARDITIS — the inflammation of the pericardium that can occur 1-3 days after MI. The nurse should: (1) position the patient sitting upright and leaning forward for comfort, (2) report findings to the physician, (3) explain to the patient that this is a known complication — not a new heart attack. Treatment: aspirin or NSAIDs for inflammation.

Medication adherence education is a core post-MI nursing responsibility and is tested in NLE scenarios. The nurse must translate complex pharmacology into understandable patient terms while ensuring the patient understands the critical importance of NOT stopping antiplatelets.

Scenario

A post-MI patient is discharged with prescriptions for aspirin, clopidogrel, metoprolol, lisinopril, and atorvastatin. He asks the nurse why he needs 'so many medications.' He also asks where to store his nitroglycerin.

Solution

Explain each medication's purpose: Aspirin + clopidogrel prevent clots from forming again; metoprolol protects the heart by slowing it down and reducing workload; lisinopril helps the heart heal and prevents weakening; atorvastatin lowers cholesterol and stabilizes the plaques. For NTG storage: keep in a dark, cool, airtight glass bottle — not in the pocket, wallet, or near heat or light. Replace every 6 months or upon expiration.

Applications

Monitor cardiac rhythm CONTINUOUSLY in all post-MI patients in the ICU/CCU — have defibrillator immediately available at bedside.
Before administering beta-blockers, assess heart rate (hold if HR < 60 bpm) and blood pressure (hold if SBP < 90 mmHg).
Post-LMWH administration: inspect injection sites for hematoma, rotate injection sites in the abdomen, and do NOT aspirate or massage the site.
Educate patients on statin therapy: take at bedtime for most statins; report any muscle pain or weakness (myalgia) immediately.
Participate in or coordinate cardiac rehabilitation referrals — under RA 9173, nurses play a key role in health restoration and rehabilitation.

Misconceptions

MISCONCEPTION: After MI, the patient should rest completely and avoid all activity. CORRECTION: Cardiac rehabilitation involves a structured, PROGRESSIVE return to activity. Complete inactivity leads to deconditioning and worsens outcomes.
MISCONCEPTION: Pericarditis post-MI is the same as a second heart attack. CORRECTION: Post-MI pericarditis has DISTINCT features: positional and pleuritic pain, friction rub, and no new troponin elevation (or minimal rise from pericardial inflammation).
MISCONCEPTION: Statins are only for patients with high cholesterol. CORRECTION: HIGH-INTENSITY STATINS are started for ALL ACS patients regardless of baseline cholesterol — they have anti-inflammatory and plaque-stabilizing effects beyond cholesterol lowering.
MISCONCEPTION: Nitroglycerin tablets last indefinitely. CORRECTION: Nitroglycerin is unstable and degrades with light, heat, and moisture — tablets should be replaced every 6 months and stored in the ORIGINAL dark glass bottle.
MISCONCEPTION: LMWH (enoxaparin) requires aPTT monitoring just like UFH. CORRECTION: LMWH has predictable pharmacokinetics and does NOT routinely require aPTT monitoring, which is one of its clinical advantages.

Related Concepts

Cardiac Dysrhythmias and Defibrillation
Heart Failure and Pulmonary Edema
Cardiogenic Shock Management
Anticoagulation Therapy Monitoring
Patient Discharge Planning and Health Education
DOH NCD Prevention Programs

Common Exam Questions

Example

A patient 2 weeks post-MI develops fever, chest pain that worsens with inspiration, and pericardial friction rub. What complication is this? Answer: Dressler's syndrome (autoimmune pericarditis).

Approach

When a post-MI patient develops NEW symptoms, correlate them with timing: dysrhythmias = immediate/early; pericarditis = 1-3 days; heart failure = days; Dressler's syndrome = weeks. Identify the correct complication.

Question Type

Complication Recognition

Example

A patient on unfractionated heparin for ACS. What laboratory value does the nurse monitor? Answer: aPTT (activated partial thromboplastin time) — target 1.5-2.5 times the control value.

Approach

Know the monitoring parameter for each drug: UFH → aPTT; ACE inhibitors → BP, K+ level, creatinine; statins → liver enzymes, muscle pain; beta-blockers → HR and BP.

Question Type

Medication Monitoring

Example

A patient asks where to keep his nitroglycerin tablets. The nurse correctly responds: In a dark, cool, airtight glass bottle, away from heat and moisture — not in a shirt pocket close to the body.

Approach

NLE discharge teaching questions often test NITROGLYCERIN STORAGE (dark, airtight container) and the critical instruction about ANTIPLATELET ADHERENCE (never stop without physician guidance).

Question Type

Patient Teaching Priorities

Key Points To Remember

DUAL ANTIPLATELET THERAPY (Aspirin + P2Y12 inhibitor) — do NOT stop without physician approval, especially after PCI stenting.
UFH requires aPTT MONITORING; LMWH (enoxaparin) does NOT require routine aPTT monitoring.
Beta-blockers: HOLD if bradycardic, hypotensive, or severe bronchospasm is present.
ACE inhibitors: Monitor for COUGH (most common), hyperkalemia, and hypotension.
Statins: Monitor for MYALGIA and elevated liver enzymes (rhabdomyolysis risk).
VENTRICULAR FIBRILLATION = LEADING CAUSE OF DEATH in early MI — continuous cardiac monitoring is MANDATORY.
Pericarditis (1-3 days post-MI): Pleuritic chest pain, friction rub; Dressler's syndrome (2-10 weeks post-MI): autoimmune pericarditis.
Nitroglycerin storage: Dark, AIRTIGHT container — AWAY from heat, moisture, and light.
Cardiac rehab has 3 phases: Inpatient (Phase I) → Supervised outpatient (Phase II) → Long-term maintenance (Phase III).
SMOKING CESSATION is the single most impactful modifiable risk factor intervention post-MI.

Practice Problems

This scenario is the 'classic NLE STEMI case.' The ANTERIOR STEMI (V1-V4) indicates Left Anterior Descending (LAD) artery occlusion — the most common and most extensive MI. Key nursing priorities: ECG within 10 minutes (already done), aspirin immediately, IV access, continuous cardiac monitoring, pain assessment, and activate the reperfusion protocol. Note the modern O2 nuance (SpO₂ 96% = no oxygen needed) and aspirin as the first drug.

Problem

A 55-year-old male patient arrives at the emergency room with substernal chest pain radiating to the left arm for the past 50 minutes, unrelieved by 3 sublingual nitroglycerin tablets he took at home. He is diaphoretic and anxious. His BP is 110/70 mmHg, HR is 92 bpm, SpO₂ is 96% on room air. His 12-lead ECG shows ST elevation in leads V1-V4. Question 1: What is the PRIORITY nursing diagnosis? Question 2: What is the FIRST drug the nurse should administer? Question 3: Should supplemental oxygen be given? Question 4: What is the target door-to-balloon time for this patient?

Solution

Answer 1: Acute Pain related to myocardial ischemia (a physiologic/safety priority on Maslow's hierarchy). Additionally: Decreased Cardiac Output related to myocardial injury; Risk for Decreased Cardiac Tissue Perfusion. Answer 2: CHEWABLE ASPIRIN 160-325 mg — this is the first-priority drug, given immediately upon ACS recognition. Answer 3: NO — SpO₂ is 96%, which is above the threshold (90-94%). Routine oxygen in normoxic patients is not recommended per current evidence. Answer 4: Door-to-balloon time of UNDER 90 MINUTES — PCI is the preferred reperfusion for this STEMI (anterior STEMI, leads V1-V4, indicating LAD occlusion).

This scenario specifically tests understanding of ATYPICAL MI PRESENTATIONS — a high-yield NLE topic. The nursing process begins with comprehensive ASSESSMENT. Obtaining the ECG is the first actionable step. A female diabetic with unexplained fatigue and GI symptoms must be treated as a potential MI until proven otherwise. This aligns with the nurse's independent function under RA 9173: accurate comprehensive assessment and appropriate escalation of care.

Problem

A 62-year-old female diabetic patient presents to the community health center reporting 'feeling very tired and having heartburn' for the past 3 hours. She denies chest pain. Her BP is 130/85 mmHg, HR is 95 bpm, and SpO₂ is 94%. Her daughter says 'she doesn't look right.' The nurse suspects an atypical MI presentation. What should the nurse do FIRST, and why?

Solution

The nurse should OBTAIN A 12-LEAD ECG IMMEDIATELY (within 10 minutes) and prepare to draw cardiac biomarkers (troponin). This is the priority assessment action. Rationale: This patient has multiple red flags for atypical MI — she is elderly, female, diabetic (all groups prone to atypical/silent MI), presenting with fatigue and GI symptoms ('heartburn') instead of classic chest pain. Diabetic autonomic neuropathy reduces pain perception, masking typical anginal symptoms. The nurse must maintain a high index of suspicion. Additionally, SpO₂ is at 94% — borderline — so the nurse should reassess and consider applying oxygen if it drops below 94%.

This is a complex, multi-part NLE-style scenario that tests accurate knowledge of thrombolytic ABSOLUTE vs. RELATIVE contraindications, pharmacology nuances (sildenafil relates to NTG, not thrombolytics), and comprehensive post-thrombolytic nursing care. In the Philippine setting, thrombolytics are especially relevant given limited PCI access outside major urban centers.

Problem

A patient with confirmed STEMI arrives at a hospital that has no catheterization laboratory. The nearest PCI-capable center is 5 hours away. The physician decides to give alteplase (thrombolytic). The nurse screens the patient for contraindications and finds the following: the patient had an ischemic stroke 5 months ago, has a BP of 160/95 mmHg, and takes sildenafil occasionally (last dose was 3 days ago). Are there any absolute contraindications to thrombolytic therapy? What nursing actions are required post-administration?

Solution

CONTRAINDICATION SCREENING: (1) Ischemic stroke 5 months ago — 3 months is the absolute contraindication cutoff; at 5 months, this becomes a RELATIVE contraindication requiring physician risk-benefit judgment, NOT an absolute contraindication. (2) BP 160/95 mmHg — concerning but the ABSOLUTE cutoff for severe uncontrolled hypertension is usually > 180/110 mmHg; this is elevated but may be manageable. (3) Sildenafil 3 days ago — This is relevant to NITROGLYCERIN, NOT to thrombolytics. Sildenafil use does NOT contraindicate thrombolytics. In this case, there is no clear ABSOLUTE contraindication — the physician will weigh relative risks. POST-ADMINISTRATION NURSING CARE: (1) Minimize invasive procedures — no unnecessary venipunctures, no IM injections; (2) Apply firm pressure (10-15 min) to all puncture sites; (3) Monitor for bleeding: urine (hematuria), stools (melena), IV sites, neurologic status; (4) Monitor neurological signs every 15-30 minutes for intracranial hemorrhage; (5) Monitor ECG for reperfusion signs (ST normalization, reperfusion dysrhythmias); (6) Report any sudden headache, confusion, or neurological changes IMMEDIATELY.

This scenario tests the critical clinical skill of DIFFERENTIATING post-MI pericarditis from reinfarction. The POSITIONAL and PLEURITIC nature of pain, friction rub, unchanged troponin, and low-grade fever are diagnostic of pericarditis. The NLE may ask the nurse to differentiate this from new MI (which would have new ECG changes and rising troponin). Additionally, Beck's Triad monitoring is a critical safety component of pericarditis nursing care.

Problem

On post-MI day 2, Mr. Cruz develops new chest pain described as sharp and stabbing, rated 7/10, that worsens significantly when he takes a deep breath and when he lies flat. It improves when he leans forward. On auscultation, the nurse hears a scratchy, grating sound over the precordium that is synchronous with the heartbeat. His temperature is 37.8°C. ECG shows no new ST changes. Troponin is unchanged from yesterday's level. What is the most likely complication? What is the priority nursing intervention?

Solution

COMPLICATION: POST-MI PERICARDITIS — classic presentation includes: (1) Sharp, pleuritic chest pain (worsens with inspiration and lying flat, improves with sitting forward); (2) Pericardial FRICTION RUB on auscultation; (3) Low-grade fever; (4) No new ECG changes (or diffuse saddle-shaped ST elevation in pericarditis, but no new localized changes indicating new infarction); (5) Unchanged troponin (rules out reinfarction). PRIORITY NURSING INTERVENTION: (1) POSITION: Assist the patient to sit upright and lean forward (relieves pain by lifting the pericardium away from the heart); (2) REPORT immediately to the physician; (3) Administer anti-inflammatory medication as ordered (aspirin or NSAIDs — first-line treatment for post-MI pericarditis); (4) Reassure the patient that this is a known post-MI complication, not another heart attack; (5) Monitor for signs of CARDIAC TAMPONADE (hypotension, muffled heart sounds, distended neck veins — Beck's Triad) as a potential complication of pericarditis.

Medication adherence is one of the most tested discharge teaching topics in the NLE. The clopidogrel answer addresses BOTH the clinical danger of stopping antiplatelets AND the Filipino reality of medication cost — integrating cultural competence and the Philippine healthcare context (PhilHealth coverage). The NTG storage teaching tests specific pharmacology knowledge. Under RA 9173, patient education is an independent nursing function.

Problem

A patient is being discharged after recovering from an MI. The discharge nurse provides medication and lifestyle teaching. The patient asks: 'Can I stop taking my Plavix (clopidogrel) next week? I ran out and it's expensive.' He also asks: 'Where should I keep my nitroglycerin tablets?' Provide the correct responses for both questions.

Solution

RESPONSE 1 — CLOPIDOGREL: 'Sir, it is very important that you do NOT stop your Plavix without first talking to your cardiologist. After a heart attack and especially after a stent is placed, stopping this medicine too early can cause a new blockage in the artery or stent — which can be life-threatening. If cost is a concern, please let us know and we can refer you to PhilHealth benefits or a social worker to help with medication costs. This medication should be taken exactly as prescribed for the full duration.' RESPONSE 2 — NITROGLYCERIN STORAGE: 'Keep your nitroglycerin tablets in the original DARK GLASS bottle, tightly capped, in a cool and dry place at room temperature. Do NOT keep it in your pants pocket or anywhere close to your body — body heat will make it lose its effectiveness. Keep it away from light, heat, and moisture. Check the expiration date and replace it every 6 months. You will know it may be losing potency if you no longer feel a slight tingling under the tongue or a mild headache when you take it.'

Exam Preparation Tips

MASTER THE ANGINA vs. MI TABLE: Know all five differentiating features cold — cause (reversible vs. irreversible), duration (<15 min vs. >20-30 min), relief (rest/NTG vs. not relieved), biomarkers (normal vs. elevated), and ECG findings. This is asked in EVERY NLE.
MEMORIZE MONA WITH THE MODERN NUANCE: The NLE is now testing updated MONA. Remember: Aspirin = FIRST drug; O2 = only if SpO₂ < 90-94%; NTG = check BP and ask about sildenafil FIRST; Morphine = only if NTG fails. Practice identifying scenarios where each component is contraindicated.
KNOW YOUR NTG CONTRAINDICATIONS BY HEART (literally): Hypotension, Inferior/RV MI (ST elevation in leads II, III, aVF = inferior MI), Recent sildenafil/tadalafil use. If any of these are in the scenario and NTG is ordered, the nurse holds the medication and reports to the physician.
TROPONIN IS YOUR CONFIRMATION BIOMARKER: Any scenario asking 'what confirms MI?' or 'what distinguishes MI from angina?' — the answer is TROPONIN. It is the most specific and sensitive. CK-MB is useful for detecting REINFARCTION (it normalizes faster).
TIME METRICS MATTER: Door-to-BALLOON < 90 minutes for PCI (STEMI); Door-to-NEEDLE < 30 minutes for thrombolytics. ECG within 10 MINUTES. These are NLE-testable benchmarks.
ATYPICAL MI PRESENTATIONS ARE HIGH-YIELD: When the NLE describes a FEMALE patient, ELDERLY patient, or DIABETIC with vague symptoms (fatigue, dyspnea, indigestion, jaw pain) — ALWAYS suspect MI. The priority action is always: 12-lead ECG + cardiac biomarkers.
THROMBOLYTIC CONTRAINDICATIONS — MEMORIZE AS A CHECKLIST: Hemorrhagic stroke (any time), ischemic stroke (<3 months), active internal bleeding, intracranial tumor/AVM, severe uncontrolled hypertension, recent major surgery/trauma. If ANY of these are in the scenario, thrombolytics are contraindicated.
POST-THROMBOLYTIC CARE = BLEEDING PREVENTION: Minimize venipunctures, NO IM injections, apply pressure to puncture sites, monitor neurologic status (signs of intracranial bleed = sudden headache, confusion, pupil changes), monitor urine and stool for blood.
COMPLICATIONS TIMELINE: Dysrhythmias (especially VFib) = FIRST HOURS (most common cause of early death); Pericarditis = 1-3 DAYS post-MI; Dressler's syndrome = 2-10 WEEKS post-MI. Cardiogenic shock and heart failure can occur any time but especially in large MIs.
NITROGLYCERIN TEACHING PEARLS: (1) Chew/crush aspirin — swallow NTG under the tongue; (2) SIT DOWN before taking NTG (prevents falls from hypotension); (3) Max 3 doses, 5 minutes apart; (4) Call for help after the FIRST dose if pain doesn't improve; (5) Store in DARK, AIRTIGHT glass container, away from heat and light.
APPLY MASLOW'S HIERARCHY TO PRIORITIZATION: Airway, breathing, circulation problems (physiologic) ALWAYS outrank psychosocial needs. In MI, priorities: relieve pain (physiologic) → restore perfusion → prevent complications → then education (psychosocial).
PHILIPPINE CONTEXT QUESTIONS: The NLE may reference PhilPEN screening, the DOH NCD program, or rural hospital settings where PCI is unavailable. Thrombolytics remain very clinically relevant for provincial nurses. Know your referral pathways.
INFERIOR MI + RV INFARCTION PATTERN: ST elevation in leads II, III, aVF = inferior MI = right coronary artery = HIGH RISK of RV involvement. Treat with FLUIDS (IV bolus to maintain preload) NOT nitroglycerin. This is a commonly tested clinical judgment item.
NEVER STOP ANTIPLATELETS AFTER MI/STENTING: This is a priority discharge teaching point. Stopping clopidogrel or aspirin after PCI/stenting is a major cause of preventable MI death. Cost barriers (common in the Philippine setting) must be addressed through PhilHealth and social work referral.

Loading diagram…

In summary

Coronary Artery Disease, Angina, and Myocardial Infarction form a clinical continuum that every Filipino nurse must master — both for the NLE board exam and for competent, life-saving practice. In a country where cardiovascular disease is the number one killer, nurses at every level of care (from barangay health centers to intensive care units) play a critical role in prevention, recognition, and emergency management. The core conceptual framework to internalize is the CONTINUUM from stable CAD (stable angina) through unstable plaque (unstable angina) to partial occlusion with necrosis (NSTEMI) and complete occlusion with full-thickness injury (STEMI). TROPONIN is your diagnostic anchor — its elevation always signals myocardial necrosis. STEMI demands IMMEDIATE reperfusion (PCI within 90 minutes, or thrombolytics within 30 minutes if PCI is unavailable). For the NLE, the most frequently tested nuances are: (1) the UPDATED MONA — aspirin first, oxygen only for hypoxia, NTG with contraindication checks, morphine only for refractory pain; (2) NTG contraindications — hypotension, inferior/RV MI, recent sildenafil; (3) thrombolytic contraindications — hemorrhagic stroke, recent ischemic stroke, active bleeding; (4) ATYPICAL MI in women, elderly, and diabetics; and (5) post-MI COMPLICATIONS — VFib as the leading early killer, pericarditis at 1-3 days, and Dressler's syndrome at 2-10 weeks. As a future Registered Nurse under RA 9173, your role extends beyond medication administration — it encompasses comprehensive assessment, patient and family education, risk factor counseling, and advocacy for timely access to reperfusion therapy. Use the NURSING PROCESS: Assess accurately, diagnose precisely, plan systematically, intervene promptly, and evaluate continuously. In ACS, minutes truly matter — and it is often the nurse who first identifies the warning signs, initiates the protocol, and keeps the patient alive long enough for definitive treatment. Study these concepts with clinical scenarios, not just isolated facts. The NLE rewards nurses who can APPLY knowledge to patient care — and that is exactly the kind of nurse the Philippines needs.

Previous chapter

Cardiovascular Assessment and Diagnostics

Next chapter

Heart Failure and Cardiac Dysrhythmias

Ready to practise for the NLE 2026?

Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target NLE exam date.

Start free See the full NLE guide NLE preparation guide

← Back to Cardiovascular Nursing hub